Chapter- 1: INTRODUCTION - Complimentary 3

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 4

Table Summary : GLOBAL MARKET FOR "SILENT" CANCERS, THROUGH 2019
Figure Summary : GLOBAL MARKET SHARE FOR

Chapter- 3: OVERVIEW 7

CANCER: A GLOBAL PERSPECTIVE
GROWING PROBLEM
MARKET DYNAMICS
SOME LEADING ANTICANCER DRUGS
ASYMPTOMATIC CANCER

Chapter- 4: BRAIN CANCER 10

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW DEVELOPMENTS IN RESEARCH
MARKET

Chapter- 5: CANCER OF THE MOUTH AND LARYNX 7

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
LARYNGEAL CANCER
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 6: CANCER OF THE ESOPHAGUS 6

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 7: LIVER CANCER 7

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
OTHER PRIMARY LIVER CANCERS
METASTASES
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 8: RENAL CANCER 8

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 9: CANCER OF THE PANCREAS 9

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 10: CANCER OF THE CERVIX 9

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 11: OVARIAN CANCER 17

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
OVARIAN CANCER SCREENING
NEW DEVELOPMENTS IN TREATMENT
MARKET

Chapter- 12: TUMOR MARKERS 10

SCREENING AND EARLY DETECTION
DIAGNOSING CANCER
MONITORING
TUMOR MARKERS FOUND ON THE CANCER ITSELF
NEW DIRECTIONS IN TUMOR MARKER RESEARCH

Chapter- 13: COMPANY PROFILES 18

ABBOTT LABORATORIES
ADVAXIS
AMGEN
APP PHARMACEUTICALS
ASTRAZENECA
BAYER
BIONUMERIK PHARMACEUTICALS
BOEHRINGER INGELHEIM GMBH
BRISTOL-MYERS SQUIBB
CELL THERAPEUTICS INC.
CHUGAI PHARMACEUTICAL
CLOVIS ONCOLOGY
DENDREON CORP.
DIGENE CORP.
EISAI INC.
ELI LILLY AND COMPANY
ENDOCYTE
FUJIREBIO DIAGNOSTICS
GE HEALTHCARE
GENENTECH
GLAXOSMITHKLINE
ISA PHARMACEUTICALS
JOHNSON & JOHNSON
LPATH
MERCK
MYRIAD GENETICS
NOVOCURE
OASMIA PHARMACEUTICAL
ONCOLYTICS
OXIGENE
PFIZER
PROVISTA DIAGNOSTICS
QIAGEN
QUEST DIAGNOSTICS
RADIENT PHARMACEUTICALS
ROCHE DIAGNOSTICS
SANOFI
TELIK INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
ZILICO

Chapter- 14: APPENDIX 1: GLOSSARY 8

List of Tables

Summary Table : GLOBAL MARKET FOR "SILENT" CANCERS, THROUGH 2019
Table 1 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR BRAIN CANCER
Table 2 : GLOBAL AND U.S. BRAIN CANCER MARKET, THROUGH 2019
Table 3 : BRAIN CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 4 : BRAIN CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 5 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR HEAD AND NECK CANCER
Table 6 : GLOBAL AND U.S. MOUTH AND LARYNX CANCER MARKET, THROUGH 2019
Table 7 : MOUTH AND LARYNX CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 8 : CANCER OF MOUTH AND LARYNX FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 9 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR ESOPHAGEAL CANCER
Table 10 : GLOBAL AND U.S. ESOPHAGEAL CANCER MARKET, THROUGH 2019
Table 11 : ESOPHAGEAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 12 : ESOPHAGEAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 13 : LIVER CANCER: NEW DEVELOPMENTS IN RESEARCH
Table 14 : GLOBAL AND U.S. LIVER CANCER MARKET, THROUGH 2019
Table 15 : LIVER CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 16 : LIVER CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 17 : RENAL CANCER: NEW RESEARCH DEVELOPMENTS
Table 18 : GLOBAL AND U.S. RENAL CANCER MARKET, THROUGH 2019
Table 19 : RENAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 20 : RENAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 21 : PANCREATIC CANCER: NEW RESEARCH DEVELOPMENTS
Table 22 : GLOBAL AND U.S. PANCREATIC CANCER MARKET, THROUGH 2019
Table 23 : PANCREATIC CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 24 : PANCREATIC CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 25 : NEW RESEARCH DEVELOPMENTS IN CERVICAL CANCER
Table 26 : GLOBAL AND U.S. CERVICAL CANCER MARKET, THROUGH 2019
Table 27 : CERVICAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 28 : CERVICAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 29 : NEW DEVELOPMENTS IN OVARIAN CANCER RESEARCH
Table 30 : GLOBAL AND U.S. OVARIAN CANCER MARKET, THROUGH 2019
Table 31 : OVARIAN CANCER MARKET, FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 32 : OVARIAN CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019